Literature DB >> 19881096

Ultrasound characterization of breast masses.

Sudheer Gokhale1.   

Abstract

A lump in the breast is a cause of great concern. High frequency, high-resolution USG helps in its evaluation. This is exemplified in women with dense breast tissue where USG is useful in detecting small breast cancers that are not seen on mammography. Several studies in the past have addressed the issue of differentiating benign from malignant lesions in the breast. The American College of Radiology has also brought out a BIRADS-US classification system for categorizing focal breast lesions.

Entities:  

Year:  2009        PMID: 19881096      PMCID: PMC2766883          DOI: 10.4103/0971-3026.54878

Source DB:  PubMed          Journal:  Indian J Radiol Imaging        ISSN: 0970-2016


Introduction

Breast cancer is among the most common causes of cancer deaths today, coming fifth after lung, stomach, liver and colon cancers. It is the most common cause of cancer death in women.[1] In 2005 alone, 519 000 deaths were recorded due to breast cancer.[1] This means that one in every 100 deaths worldwide and almost one in every 15 cancer deaths were due to breast cancer. Refinement of high-frequency technology, particularly with 7.5–13 MHz probes, has brought out a totally new facet in USG breast imaging.[2] For example: High-density probes provide better lateral resolution Harmonic imaging leads to improved resolution and reduced reverberation and near-field artifacts Real-time compound scanning results in increased tissue contrast resolution Extended or panoramic views provide a better perspective of the lesion in relation to the rest of the breast Harmonic imaging and real-time compounding has been shown to improve image resolution and lesion characterization.[34] More recently, USG elastography seems to be quite promising. Initial results indicate that it can improve the specificity and positive predictive value of USG in the characterization of breast masses.[5] The reason why any lesion is visible on mammography or USG is the relative difference in the density and acoustic impedance of the lesion, respectively, as compared to the surrounding breast tissue. This is exemplified in women with dense breast tissue, where USG is useful in detecting small breast cancers that are not detected on mammography.[6]

Normal breast parenchymal patterns

In the young non-lactating breast, the parenchyma is primarily composed of fibroglandular tissue, with little or no subcutaneous fat. With increasing age and parity, more and more fat gets deposited in both the subcutaneous and retromammary layers[7] [Figure 1].
Figure 1

Normal breast. Mid transverse scan of a normal breast. The fibroglandular parenchyma is echogenic (arrowheads) and is surrounded by hypoechoic fat (*)

Normal breast. Mid transverse scan of a normal breast. The fibroglandular parenchyma is echogenic (arrowheads) and is surrounded by hypoechoic fat (*)

Abnormal appearances

Breast cysts

Breast cysts are the commonest cause of breast lumps in women between 35 and 50 years of age.[7] A cyst occurs when fluid accumulates due to obstruction of the extralobular terminal ducts, either due to fibrosis or because of intraductal epithelial proliferation. A cyst is seen on USG as a well-defined, round or oval, anechoic structure with a thin wall [Figure 2A]. They may be solitary or multiple [Figure 2B].
Figure 2 (A–D)

Cysts. Cysts usually reveal thin walls and through transmission (A). An inflamed cyst (B) reveals A thick edematous wall (arrow) with internal layering of thick/thin fluid (arrowhead). A galactocele (C) reveals diffuse low-level echoes in the cyst. chronic abscess (D) seen in this extended views shows an an irregular pseudo-wall (arrow) with dirty internal echoes due to pus or debris (X).

Cysts. Cysts usually reveal thin walls and through transmission (A). An inflamed cyst (B) reveals A thick edematous wall (arrow) with internal layering of thick/thin fluid (arrowhead). A galactocele (C) reveals diffuse low-level echoes in the cyst. chronic abscess (D) seen in this extended views shows an an irregular pseudo-wall (arrow) with dirty internal echoes due to pus or debris (X). Complex cyst: When internal echoes or debris are seen, the cyst is called a complex cyst. These internal echoes may be caused by floating cholesterol crystals, pus, blood or milk of calcium crystals.[8] [Figure 2C].

Chronic abscess of the breast

Patients may present with fever, pain, tenderness to touch and increased white cell count. Abscesses are most commonly located in the central or subareolar area.[9] An abscess may show an ill-defined or a well-defined outline. It may be anechoic or may reveal low-level internal echoes and posterior enhancement [Figure 2D].

Fibrocystic breast condition

This condition is referred to by many different names: fibrocystic disease, fibrocystic change, cystic disease, chronic cystic mastitis or mammary dysphasia. The USG appearance of the breast in this condition is extremely variable since it depends on the stage and extent of morphological changes. In the early stages, the USG appearance may be normal, even though lumps may be palpable on clinical examination. There may be focal areas of thickening of the parenchyma, with or without patchy increase in echogenicity [Figure 3A]. Discrete single cysts or clusters of small cysts may be seen in some [Figure 3B and C]. Focal fibrocystic changes may appear as solid masses or thin-walled cysts. About half of these solid masses are usually classified as indeterminate and will eventually require a biopsy.[10]
Figure 3 (A-C)

Fibrocystic change. Extended view images (A, B) show a focal area of thickening of the breast parenchyma (A) with patchy increase in echogenicity (arrows) and scattered, discrete, thin-walled cysts (arrowheads in B). The “lump” may shows a combination of clustered tiny cysts and thickened parenchyma (arrows in C)

Fibrocystic change. Extended view images (A, B) show a focal area of thickening of the breast parenchyma (A) with patchy increase in echogenicity (arrows) and scattered, discrete, thin-walled cysts (arrowheads in B). The “lump” may shows a combination of clustered tiny cysts and thickened parenchyma (arrows in C)

Duct ectasia

This lesion has a variable appearance. Typically, duct ectasia may appear as a single tubular structure filled with fluid or sometimes may show multiple such structures as well. Old cellular debris may appear as echogenic content. If the debris fills the lumen, it can be sometimes mistaken for a solid mass, unless the tubular shape is picked up[11] [Figure 4].
Figure 4 (A, B)

Chronic duct ectasia. Longitudinal image (A) shows a dilated duct containing inspissated debris (arrow) is seen. In crosssection (B), the intraductal debris may appear as a focal lesion (arrowheads)

Chronic duct ectasia. Longitudinal image (A) shows a dilated duct containing inspissated debris (arrow) is seen. In crosssection (B), the intraductal debris may appear as a focal lesion (arrowheads)

Fibroadenoma

Fibroadenoma is an estrogen-induced tumor that forms in adolescence. It is the third most common breast lesion after fibrocystic disease and carcinoma. It usually presents as a firm, smooth, oval-shaped, freely movable mass.[12] It is rarely tender or painful. The size is usually under 5 cm, though larger fibroadenomas are known. Fibroadenomas are multiple in 10–20% and bilateral in 4% of cases. Calcifications may occur. On USG, it appears as a well-defined lesion [Figure 5]. A capsule can usually be identified. The echotexture is usually homogenous and hypoechoic as compared to the breast parenchyma, and there may be low-level internal echoes. Typically, the transverse diameter is greater than the anteroposterior diameter [Figure 5]. In a small number of patients, the mass may appear complex, hyperechoic or isoechoic. A similar USG appearance may be seen with medullary, mucinous or papillary carcinoma.[13]
Figure 5

Fibroadenoma. Transvere image reveals a typical larger transverse than anteroposterior diameter, homogenous echotexture, and a thin capsule (arrowheads)

Fibroadenoma. Transvere image reveals a typical larger transverse than anteroposterior diameter, homogenous echotexture, and a thin capsule (arrowheads)

Cystosarcoma phyllodes

This is a large lesion that presents in older women. Some authors consider it to be a giant fibroadenoma. The mass may involve the whole of the breast. It usually reveals well-defined margins and an inhomogeneous echostructure, sometimes with variable cystic areas. The incidence of malignant change is low. [7] [Figure 6B].
Figure 6

Cystosarcoma phyllodes. Transverse scan reveals a large well-defined mass. There is inhomogeneous echotexture, with small areas of cystic degeneration (arrows)

Cystosarcoma phyllodes. Transverse scan reveals a large well-defined mass. There is inhomogeneous echotexture, with small areas of cystic degeneration (arrows)

Lipoma

Lipoma is a slow-growing, well-defined tumor. It may be a chance finding or the patient may present with complaints of increase in the size of the involved breast, though no discretely palpable mass can be made out. The tumor is soft and can be deformed by compression with the transducer. A thin capsule can usually be identified and the tumor often reveals an echogenic structure, with a stippled or lamellar appearance[13] [Figure 7A and B].
Figure 7

Lipoma. Sagittal extended view reveals a subtle echogenic mass with a reticular pattern and a well-defined, thin capsule (arrows)

Lipoma. Sagittal extended view reveals a subtle echogenic mass with a reticular pattern and a well-defined, thin capsule (arrows)

Breast ultrasound: criteria for benign lesions

Several studies have described the sonographic characteristics commonly seen in benign lesions of the breast:[1415] Smooth and well circumscribed Hyperechoic, isoechoic or mildly hypoechoic Thin echogenic capsule Ellipsoid shape, with the maximum diameter being in the transverse plane Three or fewer gentle lobulations Absence of any malignant findings

Characteristics of malignant lesions

Malignant lesions are commonly hypoechoic lesions with ill-defined borders. Typically, a malignant lesion presents as a hypoechoic nodular lesion, which is ‘taller than broader’ and has spiculated margins, posterior acoustic shadowing and microcalcifications[13] [Figure 8A–F]. Three-dimensional scanners with the capability of reproducing high-resolution images in the coronal plane provide additional important information. The spiky extensions along the tissue planes can be well seen in coronal images[16] [Figures 9A and B]. It was initially believed that color Doppler scanning would add to the specificity of USG examination, but this has not proven to be very efficacious; however, in certain situations it does help resolve the issue, particularly when there is significant vascularity present within highly cellular types of malignancies[17] [Figure 10].
Figure 8 (A–F)

Malignant lesions. Transverse scan (A) shows a typical malignant nodule that is taller than wide, with hypoechoic echotexture. Arrowheads indicate irregular spiculated margins. Some of the nodules may reveal a branching pattern (arrows in B). Sagittal view (C) shows a nodule with multilobulated margins; the presence of more than 3–4 lobulations is suspicious for malignancy. Sagittal (D) and transverse (E) scans show duct extension (arrows). ‘M’ indicates the primary site. Duct extension appears smooth in outline in cross-section (arrowheads in E). Transverse scan (F) shows a typical malignant lesion with irregular spiky margins, microcalcifications and a branching pattern. This lesion is classifiable as US-BIRADS category 4

Figure 9 (A,B)

Malignant lesion. Transverse scan (A) shows smooth margins, suggesting a category 3 lesion. A 3Dimage in the coronal plane (B) however reveals spiky margins with a sunray appearance, suggestive of a category 4 lesion

Figure 10

Malignant lesion. A smooth margin and homogenous echotexture suggest a category 3 lesion. Color Doppler reveals irregularly branching neovascularity

Malignant lesions. Transverse scan (A) shows a typical malignant nodule that is taller than wide, with hypoechoic echotexture. Arrowheads indicate irregular spiculated margins. Some of the nodules may reveal a branching pattern (arrows in B). Sagittal view (C) shows a nodule with multilobulated margins; the presence of more than 3–4 lobulations is suspicious for malignancy. Sagittal (D) and transverse (E) scans show duct extension (arrows). ‘M’ indicates the primary site. Duct extension appears smooth in outline in cross-section (arrowheads in E). Transverse scan (F) shows a typical malignant lesion with irregular spiky margins, microcalcifications and a branching pattern. This lesion is classifiable as US-BIRADS category 4 Malignant lesion. Transverse scan (A) shows smooth margins, suggesting a category 3 lesion. A 3Dimage in the coronal plane (B) however reveals spiky margins with a sunray appearance, suggestive of a category 4 lesion Malignant lesion. A smooth margin and homogenous echotexture suggest a category 3 lesion. Color Doppler reveals irregularly branching neovascularity In a landmark study in 1995, Stavros et al. established USG criteria to characterize solid breast masses [Table 1].[14]
Table 1

USG suspicious for malignancy

Finding: Solid nodulePositive predictive value
Spiculation91.8
Taller than wide81.2
Angular margins67.5
Shadowing64.9
Branching pattern64.0
Hypoechogenicity60.1
Calcifications59.6
Duct extension50.8
Branching pattern48.0
Microlobulations48.2
USG suspicious for malignancy

Discussion

Although it may be impossible to distinguish all benign from all malignant solid breast nodules using USG criteria, a reasonable goal for breast USG is to identify a subgroup of solid nodules that has such a low risk of being malignant that the option of short-interval follow-up can be offered as a viable alternative to biopsy. In a 4-year follow-up of palpable, circumscribed, noncalcified solid breast masses (similar to BI-RADS category 3), Graf et al. found that such cases can be adequately managed with short-term follow-up at 6-month intervals for 2 years.[18] Combined studies, which included USG and mammography, have demonstrated a near 100% negative predictive value for palpable breast lesions, when both are used together.[1920] In a study based on characterization of breast masses according to BIRADS-US criteria, Kwak et al. found no statistical differences between fine-needle aspiration cytology and USG with regard to sensitivity and Negative Predictive value (P > 0.05).[21] Heinig et al. also found USG characterization of breast lesions using BIRADS-US criteria to be highly accurate.[22]
  15 in total

1.  Technology update.

Authors:  C R Merritt
Journal:  Radiol Clin North Am       Date:  2001-05       Impact factor: 2.303

2.  Does 3-D sonography bring any advantage to noninvasive breast diagnostics?

Authors:  G C Meyberg-Solomayer; B Kraemer; A Bergmann; E Kraemer; U Krainick; D Wallwiener; E-F Solomayer
Journal:  Ultrasound Med Biol       Date:  2004-05       Impact factor: 2.998

3.  Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography.

Authors:  R S Shapiro; J Wagreich; R B Parsons; A Stancato-Pasik; H C Yeh; R Lao
Journal:  AJR Am J Roentgenol       Date:  1998-11       Impact factor: 3.959

4.  Palpable breast thickening: role of mammography and US in cancer detection.

Authors:  Jacqueline S Kaiser; Mark A Helvie; R Lisa Blacklaw; Marilyn A Roubidoux
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

5.  Sonographic findings in focal fibrocystic changes of the breast.

Authors:  Mahesh K Shetty; Yogesh P Shah
Journal:  Ultrasound Q       Date:  2002-03       Impact factor: 1.657

6.  Breast cancer vascularity: color Doppler sonography and histopathology study.

Authors:  W J Lee; J S Chu; C S Huang; M F Chang; K J Chang; K M Chen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.

Authors:  J Heinig; R Witteler; R Schmitz; L Kiesel; J Steinhard
Journal:  Ultrasound Obstet Gynecol       Date:  2008-09       Impact factor: 7.299

8.  Using sonography to screen women with mammographically dense breasts.

Authors:  Pavel Crystal; Selwyn D Strano; Semyon Shcharynski; Michael J Koretz
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

9.  Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast.

Authors:  Mahesh K Shetty; Yogesh P Shah; Ralph S Sharman
Journal:  J Ultrasound Med       Date:  2003-03       Impact factor: 2.153

10.  [A multicenter study for the evaluation of the diagnostic efficiency of mammography and echography in nonpalpable breast neoplasms].

Authors:  S Catarzi; G M Giuseppetti; G Rizzatto; M Rosselli Del Turco; S Baldassare; A Ancona; L Pescarini; C Di Maggio; G Sarti
Journal:  Radiol Med       Date:  1992-09       Impact factor: 3.469

View more
  12 in total

1.  Clinicopathologic profile of benign breast conditions in Indian women: prospective study based on aberrations of normal development and involution classification.

Authors:  Navneet Kaur; Nitin Agarwal; Pankaj Panwar; Kiran Mishra
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

Review 2.  Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review.

Authors:  Rongrong Guo; Guolan Lu; Binjie Qin; Baowei Fei
Journal:  Ultrasound Med Biol       Date:  2017-10-26       Impact factor: 2.998

3.  Our 20-Year Institutional Experience with Surgical Approach for Breast Hamartomas.

Authors:  Zeliha Türkyılmaz; Tahacan Aydın; Ravza Yılmaz; Semen Önder; Enver Özkurt; Mustafa Tükenmez; Mahmut Müslümanoğlu; Gülden Acunaş; Abdullah İğci; Vahit Özmen; Ahmet Dinçağ; Neslihan Cabioğlu
Journal:  Eur J Breast Health       Date:  2019-07-01

4.  Sonographic Evaluation of Incidental Synchronous Masses in Patients with Breast Cancer: Clinical Significance and Diagnostic Workup.

Authors:  Sara Rehman; Imran Khalid Niazi; Muhammad Atif Naveed; Ainy Javaid; Bushra Rehman
Journal:  Eur J Breast Health       Date:  2020-12-24

5.  Cystic (including atypical) and solid breast lesion classification using the different features of quantitative ultrasound parametric images.

Authors:  A A Kolchev; D V Pasynkov; I A Egoshin; I V Kliouchkin; O O Pasynkova
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-11-02       Impact factor: 2.924

6.  Ultrasonography methods for predicting malignancy in canine mammary tumors.

Authors:  Marcus Antonio Rossi Feliciano; Ricardo Andrés Ramirez Uscategui; Marjury Cristina Maronezi; Ana Paula Rodrigues Simões; Priscila Silva; Beatriz Gasser; Leticia Pavan; Cibele Figueira Carvalho; Júlio Carlos Canola; Wilter Ricardo Russiano Vicente
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

7.  Sonographic features that can be used to differentiate between small triple-negative breast cancer and fibroadenoma.

Authors:  Ga Young Yoon; Joo Hee Cha; Hak Hee Kim; Hee Jung Shin; Eun Young Chae; Woo Jung Choi
Journal:  Ultrasonography       Date:  2017-08-04

Review 8.  Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.

Authors:  Sylvia Annabel Dass; Kim Liu Tan; Rehasri Selva Rajan; Noor Fatmawati Mokhtar; Elis Rosliza Mohd Adzmi; Wan Faiziah Wan Abdul Rahman; Tengku Ahmad Damitri Al-Astani Tengku Din; Venugopal Balakrishnan
Journal:  Medicina (Kaunas)       Date:  2021-01-12       Impact factor: 2.430

9.  Characteristics of Breast Masses of Female Patients Referred for Diagnostic Breast Ultrasound from a Saudi Primary Health Care Setting.

Authors:  Nouf A AlShamlan; Reem S AlOmar; Omar Y Almukhadhib; Saad A Algarni; Askar K Alshaibani; Sara A Elmaki; Malak A Al Shammari; Abdulaziz M Sebiany
Journal:  Int J Gen Med       Date:  2021-03-03

10.  Comparison of Electrical Impedance Tomography and Ultrasonography for Determination of Solid and Cystic Lesion Resembling Breast Tumor Embedded in Chicken Phantom.

Authors:  L Choridah; D Kurniadi; K Ain; M F Ulum; U Mukhaiyar; A D Garnadi; N H Setyawan
Journal:  J Electr Bioimpedance       Date:  2021-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.